BackIO Biotech Overview

IO Biotech Receivables

IO Biotech's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer trimmed avg / median

Loading

IO Biotech Receivables History

Loading

IO Biotech vs. peers: Receivables Comparison

Loading

IO Biotech Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

IO Biotech (IOBT) FAQ

IO Biotech (IOBT) currently reports a receivables of $0 as of September 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore IO Biotech's receivables history and peer comparisons.

IO Biotech's receivables changed from $0 to $0 (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

IO Biotech reported $0 in receivables as of September 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for IO Biotech, and consider following IOBT for alerts when major investors trade the stock.